- All sections
- C - Chemistry; metallurgy
- C07C - Acyclic or carbocyclic compounds
- C07C 233/47 - Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of an acyclic saturated carbon skeleton
Patent holdings for IPC class C07C 233/47
Total number of patents in this class: 386
10-year publication summary
30
|
36
|
35
|
30
|
30
|
47
|
24
|
25
|
18
|
3
|
2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Givaudan SA | 1760 |
23 |
Ajinomoto Co., Inc. | 2337 |
16 |
Novartis AG | 11238 |
12 |
Societe d'Exploitation de Produits pour Les Industries Chimiques SEPPIC | 401 |
9 |
API Corporation | 211 |
8 |
Crystal PharmaTech Co., Ltd | 87 |
8 |
Rutgers, The State University of New Jersey | 1776 |
8 |
Shenzhen Salubris Pharmaceuticals Co., Ltd | 74 |
6 |
University of Mississippi | 158 |
6 |
Xwpharma Ltd. | 56 |
6 |
Unilever PLC | 3540 |
5 |
Unilever N.V. | 3440 |
5 |
Kaneka Corporation | 4445 |
5 |
Acuitas Therapeutics Inc. | 80 |
5 |
ARK Diagnostics, Inc. | 30 |
5 |
Navitor Pharmaceuticals, Inc. | 31 |
5 |
Vanda Pharmaceuticals, Inc. | 336 |
5 |
Novartis Pharmaceuticals Corporation | 53 |
4 |
BioTheryX, Inc. | 100 |
4 |
Suzhou Pengxu PharmaTech Co., Ltd. | 37 |
4 |
Other owners | 237 |